Publication | Open Access

Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure

InflammationLiver FibrosisHepatologyImproved SurvivalLiver PhysiologyNon-selective Beta BlockersImmunologyReduced SeverityHepatology InflammationHepatotoxicityPharmacotherapyChronic Liver FailureAcute Liver FailureHepatology FibrosisLiver DiseaseMedicineDrug-induced Liver InjuryCirrhosis